Prof. Lin Xu 许林
Chief Physician, Professor
Department of Thoracic Surgery, Jiangsu Cancer Hospital, Nanjing
Public profile Compiled from public listings and PubMed. We do not work directly with this doctor, but we can find a specialist in this field to review your case.
Get a specialist opinionClinical focus: Central lung cancer, complex mediastinal tumors, thoracoscopy, and comprehensive lung cancer treatment.
Dr. Xu graduated from Sichuan West China University of Medical Sciences in 1983 and earned a doctoral degree in surgery from Soochow University in 2007. With over 30 years of experience, Dr. Xu performed advanced training at Shanghai Chest Hospital and studied as a visiting scholar at the University of Alberta, Canada. Dr. Xu leads multiple research projects and holds eight national patents.
Professional roles
- Head of national and provincial lung cancer societies
- Head of national and provincial thoracoscopy societies
Name order: in Chinese the family name comes first (Xu Lin). Papers usually list the name as Lin Xu or Xu L.
Selected publications
184 papers on PubMed matched by name and affiliation; 30 as first or senior author since 2016. Most recent first- or senior-author papers:
- Cancers (Basel), 2026 (senior author): Integrated Analysis Identifies a TRPM4-Related Sodium Overload Signature with Prognostic Value and Experimentally Validates RNPEPL1 in Lung Adenocarcinoma. PubMed 42649955
- BMC Cancer, 2026 (senior author): Spatial nodal pattern refines disease-free survival stratification beyond pathological N stage in resected esophageal squamous cell carcinoma. PubMed 42163143
- Crit Rev Immunol, 2026 (senior author): Fusion Gene EPHB4-MET Driven by HOXA9 and Exerted Oncogenic Activity in Non-Small Cell Lung Cancer. PubMed 42224677
- Am J Cancer Res, 2025 (senior author): Factors associated with survival in patients with spinal metastases from lung cancer. PubMed 41523252
- J Thorac Dis, 2025 (senior author): Single-cell and spatial transcriptome landscapes reveal the spatial immune defense pattern shared by primary and brain metastatic lung adenocarcinoma. PubMed 41376899
- J Biochem Mol Toxicol, 2025 (senior author): LINC00942 Accelerates Esophageal Cancer Progression by Raising PRKDC Through Interaction With PTBP1. PubMed 40103322
- Zhongguo Fei Ai Za Zhi, 2024 (senior author): [Mutational Signatures Analysis of Micropapillary Components and Exploration of ZNF469 Gene in Early-stage Lung Adenocarcinoma with Ground-glass Opacities]. PubMed 38151328
- Front Mol Biosci, 2023 (senior author): RelB is a potential molecular biomarker for immunotherapy in human pan-cancer. PubMed 37388242
See the full PubMed search. Automatic matching can miss papers or include a namesake at the same hospital. This name is shared by other researchers, so we checked that the papers match this doctor's specialty; this check is automatic.
This profile has not been reviewed by the doctor. How we build this directory.
Want a specialist to review your case?
Send your records. We find a specialist in this field who can review your case and write a treatment plan with a cost estimate.
Get a specialist opinion